Myeloid Leukemia, Acute

specific

Two major types of genetic events are crucial for the molecular pathogenesis of acute myeloid leukemias (AML): activating mutations of signal transduction intermediates and alterations in myeloid transcription factors governing hematopoietic differentiation. Both aberrant and constitutive activation of signal transduction molecules are found in about 50% of primary AML bone marrow samples, and seem to contribute to the increased proliferation and apoptosis resistance. The most common of these ac

19

Centers

19

Active Trials

Cancer Funding

Top Centers for Myeloid Leukemia, Acute(19)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
52.6
2
NCI Comprehensive
Active Research Program
52.6
3
NCI Comprehensive
Active Research Program
52.6
4
NCI Comprehensive
Active Research Program
52.6
5
NCI Comprehensive
Active Research Program
52.6
6
NCI Comprehensive
Active Research Program
52.6
752.6
8
NCI Comprehensive
Active Research Program
52.6
9
NCI Comprehensive
Active Research Program
52.6
10
Active Research Program
52.6
11
Active Research Program
52.6
12
NCI Comprehensive
Active Research Program
52.6
13
NCI Clinical
Active Research Program
52.6
14
NCI Comprehensive
Active Research Program
52.6
15
Active Research Program
52.6
16
Active Research Program
52.6
17
Active Research Program
52.6
18
Active Research Program
52.6
19
Active Research Program
52.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →